Janet P Tate
Overview
Explore the profile of Janet P Tate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
3489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wrona A, Justice A, Tate J, Rentsch C, Gordon K, Kidwai-Khan F, et al.
Cannabis
. 2025 Feb;
8(1):177-190.
PMID: 39968492
Objective: While cannabis use is common among people with HIV (PWH), there have been few studies examining the association of use with health outcomes among PWH. We aimed to evaluate...
2.
McGinnis K, Justice A, Marconi V, Rodriguez-Barradas M, Hauser R, Oursler K, et al.
Front Med (Lausanne)
. 2025 Jan;
11():1532350.
PMID: 39845833
[This corrects the article DOI: 10.3389/fmed.2023.1342466.].
3.
Lo Re 3rd V, Newcomb C, Carbonari D, Mezochow A, Hennessy S, Rentsch C, et al.
Pharmacoepidemiol Drug Saf
. 2024 Dec;
33(12):e70069.
PMID: 39662972
Background: Studies evaluating the hepatic safety of medications have been limited by the inability to control for confounding from receipt of other hepatotoxic drugs. Objective: The objective of this study...
4.
Ilagan-Ying Y, Gordon K, Tate J, Lim J, Torgersen J, Lo Re 3rd V, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2443608.
PMID: 39504020
Importance: Hepatocellular carcinoma (HCC) is typically detected only at advanced stages when treatment options are limited. Most of the current HCC risk models focus on patients with viral hepatitis or...
5.
Haque L, Tate J, Chew M, Caniglia E, Taddei T, Lo Re 3rd V
Pharmacoepidemiol Drug Saf
. 2024 Oct;
33(11):e70024.
PMID: 39477692
Purpose: Accurate identification of hepatic decompensation is essential for pharmacoepidemiologic research among patients with chronic liver disease. Methods: An algorithm using ≥ 1 inpatient or ≥ 2 outpatient International Classification...
6.
Torgersen J, Mezochow A, Newcomb C, Carbonari D, Hennessy S, Rentsch C, et al.
JAMA Intern Med
. 2024 Jun;
184(8):943-952.
PMID: 38913369
Importance: Current approaches to classify the hepatotoxic potential of medications are based on cumulative case reports of acute liver injury (ALI), which do not consider the size of the exposed...
7.
Torgersen J, Skanderson M, Kidwai-Khan F, Carbonari D, Tate J, Park L, et al.
Hepatol Commun
. 2024 Jun;
8(7).
PMID: 38896066
Background: Steatotic liver disease (SLD) is a growing phenomenon, and our understanding of its determinants has been limited by our ability to identify it clinically. Natural language processing (NLP) can...
8.
McGinnis K, Justice A, Marconi V, Rodriguez-Barradas M, Hauser R, Oursler K, et al.
Front Med (Lausanne)
. 2024 Feb;
10():1342466.
PMID: 38356736
Introduction: As people age with HIV (PWH), many comorbid diseases are more common than among age matched comparators without HIV (PWoH). While the Veterans Aging Cohort (VACS) Index 2.0 accurately...
9.
Justice A, Tate J, Howland F, Gaziano J, Kelley M, McMahon B, et al.
Eur Urol Oncol
. 2024 Jan;
7(4):923-932.
PMID: 38171965
Background: An electronic health record-based tool could improve accuracy and eliminate bias in provider estimation of the risk of death from other causes among men with nonmetastatic cancer. Objective: To...
10.
Weinstein E, Stephens-Shields A, Newcomb C, Silibovsky R, Nelson C, ODonnell J, et al.
JAMA Netw Open
. 2023 Oct;
6(10):e2340457.
PMID: 37906194
Importance: Despite the frequency of total knee arthroplasty (TKA) and clinical implications of prosthetic joint infections (PJIs), knowledge gaps remain concerning the incidence, microbiological study results, and factors associated with...